Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers.

[1]  B. Erickson,et al.  Radiation Therapy for Endometrial Cancer: 4 An ASTRO Clinical Practice Guideline , 2022 .

[2]  A. Jhingran.  Updates in the treatment of vaginal cancer , 2022, International Journal of Gynecological Cancer.

[3]  N. Taunk.  The role of proton therapy in gynecological radiation oncology , 2022, International Journal of Gynecological Cancer.

[4]  S. Kannan,et al.  Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Kirisits,et al.  MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. , 2021, The Lancet. Oncology.

[6]  Yi Luan,et al.  Proton radiotherapy to preserve fertility and endocrine function: a translational investigation Proton therapy spares ovarian function and reserve in mice. , 2020, International journal of radiation oncology, biology, physics.

[7]  B. Erickson,et al.  Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. , 2020, Practical radiation oncology.

[8]  A. Mahajan,et al.  Carbon Ion Therapy: A Modern Review of an Emerging Technology , 2020, Frontiers in Oncology.

[9]  W. E. Richards,et al.  Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer. , 2019, The New England journal of medicine.

[10]  Radhe Mohan,et al.  Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. , 2019, Medical physics.

[11]  D. Aoki,et al.  Cancer of the cervix uteri , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  Lei Zhao,et al.  Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis , 2018, Radiation oncology.

[13]  B. Yaremko,et al.  Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Langen,et al.  Concepts of PTV and Robustness in Passively Scattered and Pencil Beam Scanning Proton Therapy. , 2018, Seminars in radiation oncology.

[15]  S. Both,et al.  Proton Therapy Reduces Normal Tissue Dose in Extended-Field Pelvic Radiation for Endometrial Cancer. , 2018, International journal of particle therapy.

[16]  H. Putter,et al.  Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial , 2018, The Lancet. Oncology.

[17]  J. Debus,et al.  Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons – the APROVE-trial , 2017, Radiation oncology.

[18]  L. Stalpers,et al.  Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy , 2017, Strahlentherapie und Onkologie.

[19]  N. Taku,et al.  Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer. , 2016, International journal of radiation oncology, biology, physics.

[20]  H. Putter,et al.  Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial. , 2015, International journal of radiation oncology, biology, physics.

[21]  S. Marnitz,et al.  Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation – an intraindividual comparison , 2015, Radiation oncology.

[22]  R. Phurailatpam,et al.  Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. , 2014, International journal of radiation oncology, biology, physics.

[23]  Yashuang Zhao,et al.  Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis , 2012, Radiation Oncology.

[24]  S. Both,et al.  Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies. , 2012, International journal of radiation oncology, biology, physics.

[25]  Issam El Naqa,et al.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. , 2011, International journal of radiation oncology, biology, physics.

[26]  W. Small,et al.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. , 2008, International journal of radiation oncology, biology, physics.

[27]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  B N Bundy,et al.  A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. , 1999, Gynecologic oncology.